You are Trying to View a Premium Article

Daily News You Can't Find Anywhere Else

GlaxoSmithKline Axing 720 at Belgian Vaccines Hub

pharmaceutical

Industry Segment: Pharmaceutical & Biotech | Word Count: 747 Words

GALWAY, IRELAND--February 19, 2020--Written by Martin Lynch, European News Editor for Industrial Info (Galway, Ireland)--GlaxoSmithKline (NYSE:GSK) (GSK) (Brentford, England) is laying off 720 workers at its Belgian vaccines manufacturing operation in Wavre.

Within this article: Details job cuts, operations in Belgium, plans to split the company in two, financial performance

This Premium Article can be purchased individually or as part of a subscription

Subscribe Now! All Fields Required...

Subscription Type: Pricing Help?

  • Pay-Per-Article - $3.95
  • Annual Subscription - $235.00
  • Annual Subscription with Archive - $395.00